Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions

被引:5
|
作者
Klemencic Kozul, Tara [1 ]
Yudina, Anna [2 ]
Donovan, Carley [1 ]
Pinto, Ashwin [1 ]
Osman, Chinar [1 ]
机构
[1] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[2] Terumo Blood & Cell Technol Europe, Zaventem, Belgium
关键词
Plasma exchange (PLEX); Intravenous immunoglobulin (IVIg); Cost-minimisation; Autoimmune neurological disorders; Cost effectiveness; INTRAVENOUS IMMUNOGLOBULIN; ADVERSE EVENTS; PLASMAPHERESIS; COMPLICATIONS; SAFETY; GUIDELINES; APHERESIS; THERAPY; UPDATE; TRIAL;
D O I
10.1186/s12913-022-08210-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Plasma exchange (PLEX) is an effective treatment for antibody-mediated neurological disorders and has been shown to be equally efficacious to intravenous immunoglobulin (IVIg) with comparable adverse event profiles. IVIg has traditionally been the preferred treatment option due to its ease of use. However, advancing technology has allowed PLEX to be performed with a centrifugal system via peripheral access as opposed to central access via a membrane filter. Methods We prospectively collected data from a cohort of patients who underwent PLEX at the Wessex Neurological Centre, UK, to perform a cost-minimisation analysis comparing PLEX to IVIg, the standard of care, between May 2019 and May 2020. Data obtained included indication, admission type (inpatient, daycase or intensive care), access (peripheral or central), number of PLEX cycles, exchange volume, patient weight, complications and clinical outcomes. The cost of PLEX delivered in an outpatient setting for an average 80kg person was calculated and compared to the equivalent cost of delivering IVIg by means of a cost-minimization model. Results The provision of PLEX was roughly half as costly when compared to what it would have been for IVIg (886 pound per exchange vs 1778 pound per infusion or 4432 pound per cycle of 5 exchanges vs 8890 pound per cycle of 5 infusions). Our cohort included a total of 44 patients who received a total of 357 PLEX exchanges during the 12-month period (the majority of which were in a daycase setting). We calculated an annual cost saving for PLEX over IVIg of 318,589 pound. The robustness of this result was confirmed by a one-way deterministic sensitivity analysis, showing the cost-effectiveness of PLEX. Conclusion Our findings demonstrate that PLEX is more cost-effective than IVIg in this setting. Our study supports the economic case for development of plasma exchange centres in regional neurology units, a case made all the more relevant in the context of constrained supplies of IVIg.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions
    Tara Klemencic Kozul
    Anna Yudina
    Carley Donovan
    Ashwin Pinto
    Chinar Osman
    BMC Health Services Research, 22
  • [2] COST-MINIMISATION ANALYSIS VERSUS COST-EFFECTIVENESS ANALYSIS, REVISITED
    Dakin, Helen
    Wordsworth, Sarah
    HEALTH ECONOMICS, 2013, 22 (01) : 22 - 34
  • [3] Cost-minimisation analysis of the pharmacological treatment of epilepsy in spain
    Rubio, M
    Lizán, L
    Badia, X
    Escartín-Siquier, AE
    López-Trigo, J
    Rufo-Campos, M
    Echarri, E
    REVISTA DE NEUROLOGIA, 2006, 42 (05) : 257 - 264
  • [4] A cost-minimisation analysis of lobectomy: thoracoscopic versus posterolateral thoracotomy
    Burfeind, William R., Jr.
    Jaik, Nikhil P.
    Villamizar, Nestor
    Toloza, Eric M.
    Harpole, David H., Jr.
    D'Amico, Thomas A.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 37 (04) : 827 - 832
  • [5] A cost-minimisation analysis of inpatient versus day surgery for gynaecological laparoscopy
    Gudex, Claire
    Sorensen, Jan
    Clausen, Ingo
    GYNECOLOGICAL SURGERY, 2007, 4 (02) : 91 - 96
  • [6] Cost-minimisation analysis of laparoscopic and open appendicectomy
    Kald, A
    Kullman, E
    Anderberg, B
    Wirén, M
    Carlsson, P
    Ringqvist, I
    Rudberg, C
    EUROPEAN JOURNAL OF SURGERY, 1999, 165 (06) : 579 - 582
  • [7] Cost-Minimisation Analysis of Sequential Treatment with Ofloxacin or Ciprofloxacin in Hospitalised Patients
    Erich Salewski
    Harry P. Bassaris
    Semra Calangu
    Ruth Kitzes
    John Kosmidis
    Raul Raz
    Lidija Kompan
    PharmacoEconomics, 1997, 11 : 359 - 366
  • [8] Cost-minimisation analysis of sequential treatment with ofloxacin or ciprofloxacin in hospitalised patients
    Salewski, E
    Bassaris, HP
    Calangu, S
    Kitzes, R
    Kosmidis, J
    Raz, R
    Kompan, L
    PHARMACOECONOMICS, 1997, 11 (04) : 359 - 366
  • [9] COST-MINIMISATION ANALYSIS OF DEXMEDETOMIDINE VERSUS PROPOFOL IN MECHANICAL VENTILATED PATIENTS AT ICU
    Athanazio, R.
    Maldini, P.
    Roa, S.
    Turunen, H.
    Silva, C.
    VALUE IN HEALTH, 2015, 18 (07) : A842 - A843